Lycium barbarum Polysaccharide Mediated the Antidiabetic and Antinephritic Effects in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats via Regulation of NF- B

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Du, Mingzhao ^a   Hu, Xinyu ^b   Kou, Ling ^a   Zhang, Baohai ^a   Zhang, Chaopu ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b Changchun Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GLUCOSE; GLUTATHIONE PEROXIDASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 6; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; CYTOKINE; FAT INTAKE; GLUCOSE BLOOD LEVEL; HERBACEOUS AGENT; LYCIUM BARBARUM POLYSACCHARIDE; STREPTOZOCIN; UREA; URINARY TRACT AGENT;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEPHRITIC EFFECT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LIPID DIET; LOW DRUG DOSE; LYCIUM BARBARUM; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; RENAL PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOSE RESPONSE; DRUG POTENTIATION; FAT INTAKE; IMMUNOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; MALE; METFORMIN; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RENAL AGENTS; STREPTOZOCIN; TREATMENT OUTCOME; UREA;

EID: 84971385367     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/3140290     Document Type: Article

References (39)

1. B. A. Sheikh, L. Pari, A. Rathinam, and R. Chandramohan, "Trans-anethole, a terpenoid ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin induced diabetic rats, " Biochimie, vol. 112, pp. 57-65, 2015.
2. W. Kerner and J. Brückel, "Definition, classification and diagnosis of diabetes mellitus, " Experimental and Clinical Endocrinology and Diabetes, vol. 122, no. 7, pp. 384-386, 2014.
3. G. Winkler, T. Hidvegi, G. Vandorfi et al., "Risk-stratified screening for type 2 diabetes in adult subjects: results from Hungary, " Diabetologia, vol. 54, p. S119, 2011.
4. Y. Pan, Y. Huang, Z. Wang et al., "Inhibition ofMAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy, " Journal of Cellular and Molecular Medicine, vol. 18, no. 2, pp. 231-241, 2014.
5. N. M. Elsherbiny, M. El-Sherbiny, and E. Said, "Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib, " Journal of Physiology and Biochemistry, vol. 71, no. 4, pp. 635-648, 2015.
6. J. Q. Wu, T. R. Kosten, and X. Y. Zhang, "Free radicals, antioxidant defense systems, and schizophrenia, " Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 46, pp. 200-206, 2013.
7. D. Yaghobian, A. S. Don, S. Yaghobian, X. Chen, C. A. Pollock, and S. Saad, "Increased sphingosine 1-phosphatemediates inflammation and fibrosis in tubular injury in diabetic nephropathy, " Clinical and Experimental Pharmacology and Physiology, vol. 43, no. 1, pp. 56-66, 2016.
8. D. S. Kania, J. D. Gonzalvo, and Z. A. Weber, "Saxagliptin: a clinical review in the treatment of type 2 diabetes mellitus, " Clinical Therapeutics, vol. 33, no. 8, pp. 1005-1022, 2011.
9. A. J. Scheen, "Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?" Diabetes & Metabolism, vol. 33, no. 1, pp. 3-12, 2007.
10. T. Salihu Shinkafi, L. Bello, S. Wara Hassan, and S. Ali, "An ethnobotanical survey of antidiabetic plants used by Hausa-Fulani tribes in Sokoto, Northwest Nigeria, " Journal of Ethnopharmacology, vol. 172, pp. 91-99, 2015.
11. B. Pang, X.-T. Yu, Q. Zhou et al., "Effect of Rhizoma coptidis (Huang Lian) on treating diabetes mellitus, " Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 921416, 10 pages, 2015.
12. D. Yin, Y. Y. Liu, T. X. Wang et al., "Paeoniflorin exerts analgesic and hypnotic effects via adenosine A1 receptors in a mouse neuropathic pain model, " Psychopharmacology, vol. 233, no. 2, pp. 281-293, 2016.
13. S. Zareisedehizadeh, C.-H. Tan, and H.-L. Koh, "A review of botanical characteristics, traditional usage, chemical components, pharmacological activities, and safety of Pereskia bleo (Kunth) DC, " Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 326107, 11 pages, 2014.
14. K. Gao, M. Liu, J. Cao et al., "Protective effects of lycium barbarum polysaccharide on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway, " Molecules, vol. 20, no. 1, pp. 293-308, 2015.
15. S. Chen, L. Liang, Y. Wang et al., "Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo, "MolecularMedicine Reports, vol. 12, no. 5, pp. 6727-6737, 2015.
16. H. Cai, F. Liu, P. Zuo et al., "Practical application of antidiabetic efficacy of Lycium barbarum polysaccharide in patients with type 2 diabetes, "Medicinal Chemistry, vol. 11, no. 4, pp. 383-390, 2015.
17. H.-L. Tang, C. Chen, S.-K. Wang, and G.-J. Sun, "Biochemical analysis and hypoglycemic activity of a polysaccharide isolated from the fruit of Lycium barbarum L, " International Journal of Biological Macromolecules, vol. 77, pp. 235-242, 2015.
18. Y. Dong, T. Jing, Q. Meng et al., "Studies on the antidiabetic activities of Cordyceps militaris extract in diet-streptozotocininduced diabetic sprague-dawley rats, " BioMed Research International, vol. 2014, Article ID 160980, 11 pages, 2014.
19. S. Rubattu, B. Pagliaro, G. Pierelli et al., "Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress, " International Journal ofMolecular Sciences, vol. 16, no. 1, pp. 823-839, 2015.
20. M. E. Williams, "Diabetic nephropathy: the proteinuria hypothesis, " American Journal of Nephrology, vol. 25, no. 2, pp. 77-94, 2005.
21. H. Yki-Jarvinen, "Glucose toxicity, " Endocrine Reviews, vol. 13, no. 3, pp. 415-431, 1992.
22. Z. Tang, H. Gao, S. Wang, S. Wen, and S. Qin, "Hypolipidemic and antioxidant properties of a polysaccharide fraction fromEnteromorpha prolifera, " International Journal of Biological Macromolecules, vol. 58, pp. 186-189, 2013.
23. T.-T. Huang, D. Leu, and Y. Zou, "Oxidative stress and redox regulation on hippocampal-dependent cognitive functions, " Archives of Biochemistry and Biophysics, vol. 576, pp. 2-7, 2015.
24. J.-H. Park, N. S. Park, S. M. Lee, and E. Park, "Effect of Dongchunghacho rice on blood glucose level, lipid profile, and antioxidant metabolism in streptozotocin-induced diabetic rats, " Food Science and Biotechnology, vol. 20, no. 4, pp. 933-940, 2011.
25. H. Sebai, S. Selmi, K. Rtibi, A. Souli, N. Gharbi, and M. Sakly, "Lavender (Lavandula stoechas L. ) essential oils attenuate hyperglycemia and protect against oxidative stress in alloxaninduced diabetic rats, " Lipids in Health and Disease, vol. 12, article 189, 2013.
26. A. Ceriello, A. Novials, E. Ortega et al., "Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetes, " Diabetes Care, vol. 36, no. 12, pp. 4104-4108, 2013.
27. W. Hua, H.-Z. Huang, L.-T. Tan et al., "CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress, " PLoS ONE, vol. 10, no. 5, Article IDe0127507, 2015.
28. E. N. Ellis and B. H. Good, "Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus, " Metabolism, vol. 40, no. 10, pp. 1016-1019, 1991.
29. O. Boyman, A. G. Kolios, and M. E. Raeber, "Modulation of T cell responses by IL-2 and IL-2 complexes, " Clinical and Experimental Rheumatology, vol. 33, no. 4, supplement 92, pp. 54-57, 2015.
30. R. Bertelli, A. Di Donato, M. Cioni et al., "LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity, " PLoS ONE, vol. 9, no. 10, Article IDe111285, 2014.
31. T. Peters, W. Bloch, C. Wickenhauser et al., "Terminal B cell differentiation is skewed by deregulated interleukin-6 secretion in 2 integrin-deficient mice, " Journal of Leukocyte Biology, vol. 80, no. 3, pp. 599-607, 2006.
32. E. Honkanen, E. Von Willebrand, A.-M. Teppo, T. Törnroth, and C. Grönhagen-Riska, "Adhesion molecules and urinary tumor necrosis factor-in idiopathic membranous glomerulonephritis, " Kidney International, vol. 53, no. 4, pp. 909-917, 1998.
33. T. Kosugi, T. Nakayama, M. Heinig et al., "Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice, " American Journal of Physiology-Renal Physiology, vol. 297, no. 2, pp. F481-F488, 2009.
34. T. D. Gilmore, "Introduction to NF-B: players, pathways, perspectives, " Oncogene, vol. 25, no. 51, pp. 6680-6684, 2006.
35. P. Pan, Y.-J. Wang, L. Han, X. Liu, M. Zhao, and Y.-F. Yuan, "Effects of sodium houttuyfonate on expression of NF-kappaB and MCP-1 in membranous glomerulonephritis, " Journal of Ethnopharmacology, vol. 131, no. 1, pp. 203-209, 2010.
36. S. Li, Y. Zhang, and J. Zhao, "Preparation and suppressive effect of astragalus polysaccharide in glomerulonephritis rats, " International Immunopharmacology, vol. 7, no. 1, pp. 23-28, 2007.
37. S. W. O. Oh, Y.-M. Lee, S. Kim, H. J. U. Chin, D.-W. Chae, and K. Y. O. Na, "Cobalt chloride attenuates oxidative stress and inflammation through NF-B inhibition in human renal proximal tubular epithelial cells, " Journal of Korean medical science, vol. 29, supplement 2, pp. S139-S145, 2014.
38. J. Song, Y. Wang, C. Liu et al., "Cordyceps militaris fruit body extract ameliorates membranous glomerulonephritis by attenuating oxidative stress and renal inflammation via the NF-B pathway, " Food & Function, 2016.
39. S. R. Kolati, E. R. Kasala, L. N. Bodduluru et al., "BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-B pathway, " Environmental Toxicology and Pharmacology, vol. 39, no. 2, pp. 690-699, 2015.